Wolfgang Künnecke
Vorstandsvorsitzender bei 908 Devices GmbH
Aktive Positionen von Wolfgang Künnecke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
908 Devices GmbH
908 Devices GmbH Medical SpecialtiesHealth Technology Part of 908 Devices, Inc., 908 Devices GmbH is a German company that manufactures and supplies analytical devices for biotechnology monitoring. The company is based in Braunschweig, Germany. The company was founded in 2003 by Wolfgang Künnecke. Wolfgang Künnecke has been the CEO since 2003. 908 Devices was acquired by 908 Devices, Inc. on August 09, 2022 for $17.68 million. | Vorstandsvorsitzender | 01.01.2003 | - |
Vorsitzender | 01.01.2003 | - | |
Gründer | 01.01.2003 | - |
Karriereverlauf von Wolfgang Künnecke
Ehemalige bekannte Positionen von Wolfgang Künnecke
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
AUREUM REALWERT AG | Gründer | 18.11.1991 | - |
Präsident | 18.11.1991 | - |
Statistik
International
Deutschland | 3 |
Operativ
Founder | 2 |
President | 1 |
Chief Executive Officer | 1 |
Sektoral
Finance | 2 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Aureum Realwert AG
Aureum Realwert AG Financial ConglomeratesFinance Aureum Realwert AG engages in the acquisition, administration and sale of financial assets such as investments in other companies. It invests in real assets including precious metals, raw materials, and real estate. The company was founded by Wolfgang Kuennecke on November 18, 1991 and is headquartered in Berlin, Germany. | Finance |
908 Devices GmbH
908 Devices GmbH Medical SpecialtiesHealth Technology Part of 908 Devices, Inc., 908 Devices GmbH is a German company that manufactures and supplies analytical devices for biotechnology monitoring. The company is based in Braunschweig, Germany. The company was founded in 2003 by Wolfgang Künnecke. Wolfgang Künnecke has been the CEO since 2003. 908 Devices was acquired by 908 Devices, Inc. on August 09, 2022 for $17.68 million. | Health Technology |
- Börse
- Insiders
- Wolfgang Künnecke
- Erfahrung